Sector ratings Intellia Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-05-15 pm EDT			5-day change	1st Jan Change
13.67 ^USD	+4.43%		-2.98%	+52.06%

May. 12	Intellia Therapeutics, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:40 PM
May. 11	Intellia Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
INTELLIA THERAPEUTICS, INC.	1.91B	-	BB	-		-
LONZA GROUP AG	41.67B		AAA
BEONE MEDICINES AG	32.6B		-
REVOLUTION MEDICINES, INC.	30.97B	-	B	-		-
IQVIA HOLDINGS INC.	28.23B		AAA
CELLTRION, INC.	26.41B		A
ASCENDIS PHARMA A/S	14.94B	-	-	-		-		-
REGENCELL BIOSCIENCE HOLDINGS LIMITED	14.13B	-	-	-	-	-	-	-
IONIS PHARMACEUTICALS, INC.	12.27B	-	A	-		-
EUROFINS SCIENTIFIC SE	12.12B		AA
MEDPACE HOLDINGS, INC.	11.86B		BBB
PRAXIS PRECISION MEDICINES, INC.	9.55B	-	B	-		-
ABIVAX	9.11B	-	BBB	-		-
ICON PUBLIC LIMITED COMPANY	8.89B		AAA
BLUEPRINT MEDICINES CORPORATION	8.38B	-	BB	-		-	-	-
TEMPUS AI, INC.	7.89B		A			-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	7.27B		AA
BACHEM HOLDING AG	7.18B		A
QIAGEN N.V.	6.82B		AAA
BIO-TECHNE CORPORATION	6.78B		AA
Average	14.95B		A
Weighted average by Cap.			A